KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with tag drug .

Albumedix Announces Exclusive Commercialization Agreement with ThioLogics for its Proprietary Drug Conjugation Platform

Albumedix havd announced new data that supports an exclusive agreement with ThioLogics, a UCL Business (UCLB) company, to commercialize the next generation of stable albumin drug conjugates. The data demonstrates the serum stability advantages achieved by combining Albumedix's albumin-based drug delivery technology, Veltis®, with ThioLogics' site-specific Next Generation Maleimide (NGM)...
Read More About Albumedix Announces Exclusive Commercialization Agreement with ThioLogics for its Proprietary Drug Conjugation Platform »

Review on Antimicrobial Resistance

Drug-resistant infections could kill an extra 10 million people across the world every year by 2050 if they are not tackled. By this date they could also cost the world around $100 trillion in lost output: more than the size of the current world economy, and roughly equivalent to the world losing the output of the UK economy every year, for 35 years. This enormous human and economic cost was...
Read More About Review on Antimicrobial Resistance »

New Drug Approvals Hit 66-Year High

2015 has been a remarkable year for pharmaceutical innovation. What would have been a dream (or perhaps a delusion) a few years ago has happened. Last year’s new drug approvals reached 51 , besting every year since 1950. This tally includes 45 drugs approved by FDA’s Center for Drug Evaluation and Research (CDER), and 6 recombinant therapies approved by the Center for Biologics...
Read More About New Drug Approvals Hit 66-Year High »

Self-monitoring service for patients using anticoagulation drug Warfarin.

Isle of Wight Clinical Commissioning Group is piloting a self-monitoring service for patients using anticoagulation drug Warfarin. The CCG is the first to launch the new automated service from Inhealthcare, with the aim of relieving pressure on warfarin clinics. The system allows patients to self-test at home and receive their adjusted warfarin dose via INRstar anticoagulation dosing...
Read More About Self-monitoring service for patients using anticoagulation drug Warfarin. »

Japanese Legislation for Accelerating Drug Development : Webinar

Japanese Legislation for Accelerating Drug Development” Wednesday 18 November 9:00-9:45, UK Time (Presentation and Q&A)  Online event Free   UK Trade & Investment Japan Life Sciences Team is organising the webinar on  new legislations introduced by Japan's Health Ministry, which aim to support fast track opportunities for...
Read More About Japanese Legislation for Accelerating Drug Development : Webinar »

Focus on development of Nanoparticulate Antibacterials to meet the challenge of Multi Drug Resistance

EU funded Procarta workshop in 19th May 2015 May 19 @ 9:15 am - 4:45 pm The purpose of the meeting is to bring together world experts with a major interest in the field of Nanomedicine and Antimicrobial Resistance. Click “find out more” for flyer and programme –  Procarta Flyer Programme 19th May 2015 . This event is open to everyone,...
Read More About Focus on development of Nanoparticulate Antibacterials to meet the challenge of Multi Drug Resistance »
Showing 6 results.
Items per Page 25
of 1